Skip to main content

Find Clinical Trials

Home
Conditions
Mood Disorders

Clinical trial condition

Mood Disorders

Explore clinical trials studying Mood Disorders. Study availability and eligibility vary by location and protocol.

4,255 public trials 597 recruiting studies

Refine in advanced search Browse all conditions

Mood Disorders trial results

Completed

A Study of LY2979165 in Healthy Subjects

NCT01383967

Conditions: Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore

View Trial Details

Completed

Deep Brain Stimulation for Treatment-Refractory Major Depression

NCT00122031

Conditions: Behavior, Behavioral Symptoms, Depression, +4 more
Locations: Department of Psychiatry and Psychotherapy, University of Bonn Bonn, Germany

View Trial Details

Completed

A Local Register Study For Major Depression Of Paroxetine Controlled Release

NCT00368303

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
Locations: GSK Investigational Site Guangzhou, Guangdong, China

GSK Investigational Site Baoding, Hebei, China

GSK Investigational Site Changsha, Hunan, China

GSK Investigational Site Nanjing, Jiangsu, China

View Trial Details

Completed

GSK372475 Bioequivalence Study

NCT00488098

Conditions: Depressive Disorder, Healthy Subjects, Mental Disorders, +1 more
Locations: GSK Investigational Site Toronto, Ontario, Canada

View Trial Details

Completed

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

NCT00435695

Conditions: Anxiety Disorders, Depressive Disorder, Depressive Disorder and Anxiety Disorders, +3 more
Locations: GSK Investigational Site Toronto, Ontario, Canada

View Trial Details

Completed

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

NCT01263548

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder, +5 more
Locations: Mood Disorders Psychopharmacology Unit Toronto, Ontario, Canada

View Trial Details

Completed

Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder

NCT01606384

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations: Sanofi-Aventis Bridgewater, New Jersey, United States

View Trial Details

Completed

Study of the Clinical Management of Bipolar Disease

NCT01062607

Conditions: Behavior, Bipolar Disorder, Bipolar Disorders, +5 more
Locations: Research Site Salzburg, Austria

Research Site Vienna, Austria

Research Site Villach, Austria

Research Site Vöcklabruck, Austria

View all 213 locations

View Trial Details

Completed

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

NCT00789854

Conditions: Behavior, Behavioral Symptoms, Depression, +7 more
Locations: Research Site Garran, Australian Capital Territory, Australia

Research Site Brisbane, Queensland, Australia

Research Site Everton Park, Queensland, Australia

Research Site Townsville, Queensland, Australia

View all 106 locations

View Trial Details

Completed

Aripiprazole in Children and Adolescents With Bipolar I Disorder

NCT00110461

Conditions: Bipolar Disorder, Bipolar and Related Disorders, Mania, +7 more
Locations: Local Institution Scottsdale, Arizona, United States

Local Institution Little Rock, Arkansas, United States

Local Institution National City, California, United States

Local Institution Orange, California, United States

View all 53 locations

View Trial Details